Oric Pharmaceuticals Inc (ORIC)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -91.424 | -38.179 | -37.499 | -26.342 | -32.656 | -40.345 |
Return on Equity (%) | 66.318 | 34.798 | -73.817 | -27.975 | -35.985 | -45.111 |
Return on Invested Capital (%) | -105.663 | -44.477 | -39.505 | -31.13 | -43.997 | -55.869 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 23.774 | 44.342 | 7.897 | 6.923 | 4.931 | 4.108 |
Earnings Per Share | -11.855 | -13.55 | -2.009 | -1.996 | -1.977 | -1.846 |
Cash Per Share | 23.66 | 44.939 | 2.138 | 5.732 | 1.482 | 0.429 |
Working Capital Per Share | 22.824 | 42.664 | 7.84 | 5.716 | 4.326 | 3.522 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -11.855 | -13.55 | -2.009 | -1.996 | -1.977 | -1.846 |
EBITDA Per Share | -11.855 | -13.55 | -2.009 | -1.996 | -1.977 | -1.846 |
Free Cash Flow Per Share | -12.065 | -13.681 | -2.017 | -1.995 | -1.952 | -1.849 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,8M | 1,98M | 36,7M | 39,43M | 45,09M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 45,09M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 594,88M |
Ratio cours/bénéfice | -5,91 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 25,44 |
Ratio prix/valeur comptable | 2,65 |
Rendement de dividende | - |
Actions en circulation | 70,57M |
Volume moyen (1 semaine) | 213,25k |
Volume moyen (1 mois) | 307,89k |
Variation sur 52 semaines | -3,10% |
Plus haut sur 52 semaines | 16,65 |
Plus bas sur 52 semaines | 6,33 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales